Epigenetic AI

Epigenetics meets AI. Medicine meets the future.

News

Company

Extending healthspan
through precision
predictive medicine.

By anticipating future health risks, we empower people to take control of their lifelong health with confidence. Our mission is to close the gap between healthspan and lifespan—and ultimately bring it to zero.

Our Approach

Unprecedented
Precision. Driven by
Our Proprietary AI
Foundation.

The Large Epigenome Model (LEM) integrates and learns from vast epigenomic datasets alongside diverse biological data. This AI foundation model serves as the core technology accelerating precision predictive medicine across two key domains.
*Scheduled to be rolled out sequentially starting from June 2026.

Solution

A dual-engine approach empowering personal prevention and industrial innovation. We deploy our proprietary AI analytics and deep insights to reshape both fields.

An integrated platform accelerating R&D through
high-precision biological simulations—from disease prediction and intervention efficacy to compound discovery.
An R&D platform that provides a molecular-level biological simulation environment to accelerate supplement development and drug discovery.

Science SVG

From the "LEM (Large Epigenome Model)," developed to solve challenges in epigenetic aging measurement and longevity medicine, to its application across various products. Explore the current state of our research and development.

Contact SVG

We accept inquiries regarding service details, implementation, partnerships, and other business matters. Please feel free to contact us using the form below.